Combined GADD45A and Thymidine Phosphorylase Expression Levels Predict Response and Survival of Neoadjuvant-Treated Gastric Cancer Patients
- 15 April 2005
- journal article
- clinical trial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (8), 3025-3031
- https://doi.org/10.1158/1078-0432.ccr-04-1605
Abstract
Purpose: We evaluated the expression of seven therapy-related genes to predict the clinical outcome of advanced gastric cancer patients treated with a neoadjuvant chemotherapeutic protocol.Keywords
This publication has 34 references indexed in Scilit:
- Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data SetsCancer Research, 2004
- Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II studyGastric Cancer, 2003
- Role of thymidine phosphorylase on invasiveness and metastasis in lung adenocarcinomaInternational Journal of Cancer, 2003
- New prognostic indicator for non‐small‐cell lung cancer, quantitation of thymidylate synthase by real‐time reverse transcription polymerase chain reactionInternational Journal of Cancer, 2003
- A Pilot Study of Preoperative Chemoradiotherapy for Resectable Gastric CancerAnnals of Surgical Oncology, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Dihydropyrimidine Dehydrogenase and Messenger RNA Levels in Gastric Cancer: Possible Predictor for Sensitivity to 5-FluorouracilJapanese Journal of Cancer Research, 2000
- PRACTICALp-VALUE ADJUSTMENT FOR OPTIMALLY SELECTED CUTPOINTSStatistics in Medicine, 1996
- Metabolism and mechanism of action of 5-fluorouracilPharmacology & Therapeutics, 1990
- Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNABiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1985